Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valneva Signs $32M IXIARO Supply Pact with U.S. Government | Contract Pharma

What are you searching for?

Sign in
Breaking News

Valneva Signs $32M IXIARO Supply Pact with U.S. Government

Deal includes possibility of purchasing additional doses during the next twelve months.

By: Anthony Vecchione

Valneva SE inked a $32 million contract with the U.S. Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO.

The DoD will buy a minimum of $32 million worth of IXIARO vaccines with the possibility to purchase additional doses during the coming twelve months. Deliveries of the vaccine will commence immediately.

According to the company, IXIARO is the only JE vaccine approved by the U.S. FDA, having been developed through a cooperative research and development agreement with the Walter Reed Army Institute of Research. In the U.S., Valneva markets and distributes IXIARO directly to the military and private travel market.

Dipal Patel, chief commercial officer of Valneva said, “We are excited to continue our long-term relationship with the DoD. The U.S. military has trusted IXIARO for over ten years to help protect military personnel, their families, civilian government service personnel, and government contractors from this potentially deadly disease.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics